Gastrointestinal Microbiology Research Group, Institute of Microbiology, Infectious Diseases and Immunology, Berlin Institute of Health, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Department of Medicine I for Gastroenterology, Infectious Diseases and Rheumatology, Research Center ImmunoSciences (RCIS), Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Front Immunol. 2019 Jan 29;10:49. doi: 10.3389/fimmu.2019.00049. eCollection 2019.
The globally rising incidences of multidrug-resistant (MDR) (Psae) in humans and live-stock animals has prompted the World Health Organization to rate MDR Psae as serious threat for human health. Only little is known, however, regarding factors facilitating gastrointestinal Psae-acquisition by the vertebrate host and subsequently induced inflammatory sequelae. In the present study, we addressed whether subacute ileitis predisposed mice harboring a human gut microbiota for intestinal MDR Psae carriage and whether inflammatory responses might be induced following peroral challenge with the opportunistic pathogen. To accomplish this, secondary abiotic mice were associated with a human gut microbiota by fecal microbiota transplantation. Ten days later (i.e., on day 0), subacute ileitis was induced in human microbiota associated (hma) mice by peroral low-dose infection. On day 5 post-infection, mice were perorally challenged with 10 colony forming units of a clinical MDR Psae isolate by gavage and the fecal bacterial loads surveyed thereafter. Four days post-peroral challenge, only approximately one third of mice with a human gut microbiota and subacute ileitis harbored the opportunistic pathogen in the intestinal tract. Notably, the gut microbiota composition was virtually unaffected by the Psae-carriage status during subacute ileitis of hma mice. The Psae challenge resulted, however, in more pronounced intestinal epithelial apoptotic cell and T lymphocyte responses upon ileitis induction that were not restricted to the ileum, but also affected the large intestines. Higher Psae-induced abundances of T cells could additionally be observed in extra-intestinal compartments including liver, kidney, lung, and heart of hma mice with subacute ileitis. Furthermore, higher apoptotic cell numbers, but lower anti-inflammatory IL-10 concentrations were assessed in the liver of Psae as compared to mock treated mice with ileitis. Remarkably, Psae-challenge was accompanied by even more pronounced systemic secretion of pro-inflammatory cytokines such as TNF and IL-6 at day 9 post ileitis induction. In conclusion, whereas in one third of hma mice with subacute ileitis Psae could be isolated from the intestines upon peroral challenge, the opportunistic pathogen was responsible for inflammatory sequelae in intestinal, extra-intestinal, and even systemic compartments and thus worsened subacute ileitis outcome irrespective of the Psae-carrier status.
全球范围内,耐多药(MDR)(肺炎克雷伯菌)在人类和牲畜中的发病率不断上升,促使世界卫生组织将 MDR 肺炎克雷伯菌评为对人类健康的严重威胁。然而,人们对促进脊椎动物宿主胃肠道获得肺炎克雷伯菌的因素以及随后诱导的炎症后遗症知之甚少。在本研究中,我们研究了亚急性回肠炎是否使携带人类肠道微生物群的小鼠容易发生肠道 MDR 肺炎克雷伯菌携带,以及在经口感染机会性病原体后是否会引起炎症反应。为了实现这一目标,通过粪便微生物群移植将继发性无菌小鼠与人类肠道微生物群联系起来。十天后(即第 0 天),通过口服低剂量感染在人类微生物群相关(hma)小鼠中诱导亚急性回肠炎。感染后第 5 天,通过灌胃用 10 个菌落形成单位的临床 MDR 肺炎克雷伯菌分离株对小鼠进行经口挑战,并在此后调查粪便细菌负荷。经口挑战后 4 天,只有大约三分之一携带人类肠道微生物群和亚急性回肠炎的小鼠在肠道中携带机会性病原体。值得注意的是,在 hma 小鼠的亚急性回肠炎期间,肺炎克雷伯菌的携带状态对肠道微生物群组成几乎没有影响。然而,在诱导回肠炎时,肺炎克雷伯菌的挑战导致更明显的肠道上皮细胞凋亡细胞和 T 淋巴细胞反应,这些反应不仅局限于回肠,还影响大肠。在 hma 小鼠的亚急性回肠炎中,还可以观察到在肝、肾、肺和心脏等肠外部位中 T 细胞的肺炎克雷伯菌诱导的丰度更高。此外,与患有回肠炎的模拟治疗小鼠相比,在患有回肠炎的小鼠的肝脏中还评估到更高的凋亡细胞数量,但抗炎性 IL-10 浓度较低。值得注意的是,与模拟治疗的回肠炎小鼠相比,在诱导回肠炎后 9 天,肺炎克雷伯菌的挑战还伴随着更明显的全身促炎细胞因子如 TNF 和 IL-6 的分泌。总之,在三分之一的亚急性回肠炎 hma 小鼠中,经口挑战后可以从肠道中分离出肺炎克雷伯菌,但该机会性病原体导致了肠道、肠外和甚至全身部位的炎症后遗症,从而无论肺炎克雷伯菌的携带状态如何,都加重了亚急性回肠炎的结局。